Stocks · Health care · Pharmaceutical Preparations

ANI PHARMACEUTICALS INC

ANIP Clue Score55
United States Fiscal year ends December CIK 0001023024
73.89
+2.65%
Close, 9 Oct 2026 · USD

Price, with every insider trade on it

Closing prices, 12 months · point at a dot for who traded, or at the line for the close
73.89 on 9 Oct 2026
95 83 70 Oct 2025 Apr 2026 Oct 2026 13 Oct 2025 $88.61 14 Oct 2025 $88.74 15 Oct 2025 $90.10 16 Oct 2025 $91.95 17 Oct 2025 $94.79 20 Oct 2025 $95.12 21 Oct 2025 $95.38 22 Oct 2025 $93.76 23 Oct 2025 $94.90 24 Oct 2025 $94.24 27 Oct 2025 $92.86 28 Oct 2025 $93.29 29 Oct 2025 $92.23 30 Oct 2025 $91.93 31 Oct 2025 $90.60 3 Nov 2025 $94.06 4 Nov 2025 $94.48 5 Nov 2025 $92.62 6 Nov 2025 $90.23 7 Nov 2025 $90.43 10 Nov 2025 $88.93 11 Nov 2025 $88.54 12 Nov 2025 $87.27 13 Nov 2025 $84.55 14 Nov 2025 $84.02 17 Nov 2025 $81.97 18 Nov 2025 $81.07 19 Nov 2025 $80.33 20 Nov 2025 $78.52 21 Nov 2025 $79.72 24 Nov 2025 $80.98 25 Nov 2025 $83.22 26 Nov 2025 $84.36 28 Nov 2025 $84.85 1 Dec 2025 $84.47 2 Dec 2025 $82.12 3 Dec 2025 $82.67 4 Dec 2025 $82.74 5 Dec 2025 $81.77 8 Dec 2025 $81.34 9 Dec 2025 $81.67 10 Dec 2025 $82.03 11 Dec 2025 $82.13 12 Dec 2025 $80.39 15 Dec 2025 $81.51 16 Dec 2025 $81.10 17 Dec 2025 $82.35 18 Dec 2025 $82.83 19 Dec 2025 $82.85 22 Dec 2025 $80.72 23 Dec 2025 $80.73 24 Dec 2025 $82.18 26 Dec 2025 $82.41 29 Dec 2025 $81.38 30 Dec 2025 $79.42 31 Dec 2025 $78.94 2 Jan 2026 $78.43 5 Jan 2026 $78.66 6 Jan 2026 $77.48 7 Jan 2026 $79.47 8 Jan 2026 $81.04 9 Jan 2026 $76.28 12 Jan 2026 $84.35 13 Jan 2026 $82.28 14 Jan 2026 $85.03 15 Jan 2026 $85.29 16 Jan 2026 $84.83 20 Jan 2026 $85.77 21 Jan 2026 $85.52 22 Jan 2026 $85.39 23 Jan 2026 $82.99 26 Jan 2026 $81.33 27 Jan 2026 $80.45 28 Jan 2026 $79.51 29 Jan 2026 $82.00 30 Jan 2026 $81.85 2 Feb 2026 $80.00 3 Feb 2026 $79.88 4 Feb 2026 $81.27 5 Feb 2026 $81.50 6 Feb 2026 $81.84 9 Feb 2026 $80.34 10 Feb 2026 $79.91 11 Feb 2026 $76.25 12 Feb 2026 $76.70 13 Feb 2026 $77.36 17 Feb 2026 $78.90 18 Feb 2026 $77.81 19 Feb 2026 $78.10 20 Feb 2026 $77.77 23 Feb 2026 $75.10 24 Feb 2026 $76.70 25 Feb 2026 $76.30 26 Feb 2026 $77.15 27 Feb 2026 $73.90 2 Mar 2026 $75.22 3 Mar 2026 $76.10 4 Mar 2026 $76.53 5 Mar 2026 $75.60 6 Mar 2026 $74.04 9 Mar 2026 $74.81 10 Mar 2026 $75.96 11 Mar 2026 $76.29 12 Mar 2026 $72.49 13 Mar 2026 $70.49 16 Mar 2026 $72.17 17 Mar 2026 $74.28 18 Mar 2026 $74.17 19 Mar 2026 $74.82 20 Mar 2026 $74.67 23 Mar 2026 $73.92 24 Mar 2026 $73.31 25 Mar 2026 $74.07 26 Mar 2026 $74.14 27 Mar 2026 $72.82 30 Mar 2026 $73.71 31 Mar 2026 $76.90 1 Apr 2026 $75.96 2 Apr 2026 $74.21 6 Apr 2026 $77.20 7 Apr 2026 $79.47 8 Apr 2026 $79.01 9 Apr 2026 $80.14 10 Apr 2026 $78.36 13 Apr 2026 $78.31 14 Apr 2026 $78.29 15 Apr 2026 $76.48 16 Apr 2026 $78.07 17 Apr 2026 $80.92 20 Apr 2026 $81.73 21 Apr 2026 $79.94 22 Apr 2026 $80.14 23 Apr 2026 $78.06 24 Apr 2026 $78.64 27 Apr 2026 $79.60 28 Apr 2026 $78.50 29 Apr 2026 $77.97 30 Apr 2026 $79.45 1 May 2026 $80.39 4 May 2026 $82.32 5 May 2026 $84.63 6 May 2026 $84.06 7 May 2026 $83.91 8 May 2026 $81.86 11 May 2026 $78.71 12 May 2026 $79.50 13 May 2026 $80.88 14 May 2026 $79.58 15 May 2026 $78.01 18 May 2026 $79.34 19 May 2026 $80.32 20 May 2026 $82.00 21 May 2026 $82.77 22 May 2026 $82.72 26 May 2026 $81.41 27 May 2026 $81.76 28 May 2026 $81.11 29 May 2026 $78.51 1 Jun 2026 $76.71 2 Jun 2026 $74.65 3 Jun 2026 $75.23 4 Jun 2026 $79.20 5 Jun 2026 $81.11 8 Jun 2026 $80.13 9 Jun 2026 $81.20 10 Jun 2026 $81.85 11 Jun 2026 $81.65 12 Jun 2026 $81.68 15 Jun 2026 $82.29 16 Jun 2026 $83.00 17 Jun 2026 $80.52 18 Jun 2026 $79.49 22 Jun 2026 $80.58 23 Jun 2026 $82.94 24 Jun 2026 $82.72 25 Jun 2026 $83.28 26 Jun 2026 $84.50 29 Jun 2026 $84.12 30 Jun 2026 $82.78 1 Jul 2026 $83.05 2 Jul 2026 $86.03 6 Jul 2026 $85.05 7 Jul 2026 $85.99 8 Jul 2026 $84.77 9 Jul 2026 $83.78 10 Jul 2026 $82.07 13 Jul 2026 $81.08 14 Jul 2026 $80.55 15 Jul 2026 $80.82 16 Jul 2026 $81.92 17 Jul 2026 $79.20 20 Jul 2026 $77.72 21 Jul 2026 $79.15 22 Jul 2026 $77.61 23 Jul 2026 $78.53 24 Jul 2026 $77.65 27 Jul 2026 $78.37 28 Jul 2026 $81.04 29 Jul 2026 $81.78 30 Jul 2026 $80.43 31 Jul 2026 $79.24 3 Aug 2026 $80.06 4 Aug 2026 $79.20 5 Aug 2026 $79.88 6 Aug 2026 $82.63 7 Aug 2026 $78.25 10 Aug 2026 $75.76 11 Aug 2026 $74.53 12 Aug 2026 $75.12 13 Aug 2026 $74.77 14 Aug 2026 $76.54 17 Aug 2026 $76.00 18 Aug 2026 $76.87 19 Aug 2026 $78.02 20 Aug 2026 $77.32 21 Aug 2026 $75.35 24 Aug 2026 $74.17 25 Aug 2026 $75.65 26 Aug 2026 $74.56 27 Aug 2026 $73.51 28 Aug 2026 $72.83 31 Aug 2026 $73.25 1 Sep 2026 $71.92 2 Sep 2026 $73.06 3 Sep 2026 $71.99 4 Sep 2026 $71.23 8 Sep 2026 $70.23 9 Sep 2026 $70.70 10 Sep 2026 $71.46 11 Sep 2026 $70.19 14 Sep 2026 $70.40 15 Sep 2026 $72.11 16 Sep 2026 $73.59 17 Sep 2026 $75.39 18 Sep 2026 $76.14 21 Sep 2026 $78.85 22 Sep 2026 $77.91 23 Sep 2026 $74.43 24 Sep 2026 $74.04 25 Sep 2026 $74.00 28 Sep 2026 $74.83 29 Sep 2026 $72.62 30 Sep 2026 $72.65 1 Oct 2026 $72.96 2 Oct 2026 $72.18 5 Oct 2026 $72.58 6 Oct 2026 $71.52 7 Oct 2026 $71.93 8 Oct 2026 $71.98 9 Oct 2026 $73.89 Cook Meredith SR. VP, GENERAL COUNSEL & SEC. Sold on a plan $36.04K 13 Oct 2025 · at $90.09 · 0.5% of stake Gassert Chad SVP - CORP. DEV. & STRATEGY Sold at will $1.30M 12 Nov 2025 · at $89.07 · 8.5% of stake Gassert Chad SVP - CORP. DEV. & STRATEGY Sold at will $8.27K 13 Nov 2025 · at $88.00 · 0.1% of stake Cook Meredith SR. VP, GENERAL COUNSEL & SEC. Sold on a plan $34.91K 13 Nov 2025 · at $87.27 · 0.5% of stake Walsh Patrick D Director Sold at will $750.90K 13 Nov 2025 · at $86.88 · 12.3% of stake TANNENBAUM RENEE P Director Sold at will $146.07K 5 Dec 2025 · at $81.15 · 6.7% of stake Cook Meredith SR. VP, GENERAL COUNSEL & SEC. Sold on a plan $32.93K 12 Dec 2025 · at $82.32 · 0.5% of stake Davis Krista SVP, CHIEF HR OFFICER Sold on a plan $133.65K 18 Dec 2025 · at $82.40 · 2.7% of stake Cook Meredith SR. VP, GENERAL COUNSEL & SEC. Sold on a plan $42.17K 13 Jan 2026 · at $84.33 · 0.7% of stake Mutz Christopher HEAD OF RARE DISEASE Sold on a plan $538.30K 12 Feb 2026 · at $76.55 · 7.1% of stake Cook Meredith SR. VP, GENERAL COUNSEL & SEC. Sold on a plan $38.40K 13 Feb 2026 · at $76.80 · 0.7% of stake Davis Krista SVP, CHIEF HR OFFICER Sold on a plan $161.57K 19 Feb 2026 · at $77.53 · 3.9% of stake Davis Krista SVP, CHIEF HR OFFICER Sold on a plan $134.92K 20 Feb 2026 · at $77.99 · 3.4% of stake Mutz Christopher HEAD OF RARE DISEASE Sold on a plan $415.30K 20 Feb 2026 · at $78.02 · 5.9% of stake Mutz Christopher HEAD OF RARE DISEASE Sold on a plan $30.86K 2 Mar 2026 · at $74.00 · 0.4% of stake Gutwerg Ori SVP, GENERICS Sold at will $157.59K 3 Mar 2026 · at $76.50 · 2.4% of stake Walsh Patrick D Director Sold at will $445.38K 3 Mar 2026 · at $74.23 · 10.3% of stake CAREY STEPHEN P. SVP & CFO Sold at will $552.03K 5 Mar 2026 · at $75.50 · 3.8% of stake Davis Krista SVP, CHIEF HR OFFICER Sold on a plan $111.38K 6 Mar 2026 · at $75.00 · 2.5% of stake Mutz Christopher HEAD OF RARE DISEASE Sold on a plan $157.42K 6 Mar 2026 · at $74.22 · 2.0% of stake Mutz Christopher HEAD OF RARE DISEASE Sold on a plan $267.20K 9 Mar 2026 · at $74.18 · 3.7% of stake Davis Krista SVP, CHIEF HR OFFICER Sold on a plan $377.10K 9 Mar 2026 · at $74.13 · 8.9% of stake Rowland Thomas Andrew SVP, HEAD - ESTABLISHED BRANDS Sold at will $357.47K 11 Mar 2026 · at $74.91 · 11.0% of stake Cook Meredith SR. VP, GENERAL COUNSEL & SEC. Sold on a plan $36.31K 13 Mar 2026 · at $72.62 · 0.6% of stake Mutz Christopher HEAD OF RARE DISEASE Sold on a plan $226.53K 13 Mar 2026 · at $71.64 · 3.3% of stake Cook Meredith SR. VP, GENERAL COUNSEL & SEC. Sold on a plan $38.98K 13 Apr 2026 · at $77.95 · 0.6% of stake Walsh Patrick D Director Sold at will $320.82K 11 May 2026 · at $80.75 · 7.6% of stake Lalwani Nikhil PRESIDENT & CEO Sold at will $4.27M 11 May 2026 · at $77.57 · 13.6% of stake Rowland Thomas Andrew SVP, HEAD - ESTABLISHED BRANDS Sold at will $36.36K 12 May 2026 · at $79.21 · 1.2% of stake Gutwerg Ori SVP, GENERICS Sold at will $220.37K 12 May 2026 · at $79.50 · 3.4% of stake Cook Meredith SR. VP, GENERAL COUNSEL & SEC. Sold on a plan $39.08K 13 May 2026 · at $78.16 · 0.6% of stake Walsh Patrick D Director Sold at will $806.30K 13 May 2026 · at $80.63 · 20.6% of stake CAREY STEPHEN P. SVP & CFO Sold on a plan $264.96K 5 Jun 2026 · at $80.00 · 1.8% of stake HAUGHEY THOMAS Director Sold on a plan $161.76K 8 Jun 2026 · at $80.88 · 4.9% of stake Cook Meredith SR. VP, GENERAL COUNSEL & SEC. Sold on a plan $41.02K 12 Jun 2026 · at $82.03 · 0.6% of stake CAREY STEPHEN P. SVP & CFO Sold on a plan $239.74K 29 Jun 2026 · at $84.12 · 1.6% of stake CAREY STEPHEN P. SVP & CFO Sold on a plan $284.92K 2 Jul 2026 · at $86.00 · 1.8% of stake Cook Meredith SR. VP, GENERAL COUNSEL & SEC. Sold on a plan $40.92K 13 Jul 2026 · at $81.84 · 0.6% of stake CAREY STEPHEN P. SVP & CFO Sold on a plan $231.88K 29 Jul 2026 · at $81.36 · 1.6% of stake Gutwerg Ori SVP, GENERICS Sold at will $243.47K 10 Aug 2026 · at $77.00 · 4.0% of stake Cook Meredith SR. VP, GENERAL COUNSEL & SEC. Sold on a plan $37.74K 13 Aug 2026 · at $75.48 · 0.7% of stake Lalwani Nikhil PRESIDENT & CEO Sold on a plan $401.22K 25 Aug 2026 · at $74.30 · 1.5% of stake CAREY STEPHEN P. SVP & CFO Sold on a plan $207.48K 31 Aug 2026 · at $72.80 · 1.6% of stake Thoma Jeanne Director Sold on a plan $71.53K 11 Sep 2026 · at $71.53 · 3.6% of stake Cook Meredith SR. VP, GENERAL COUNSEL & SEC. Sold on a plan $35.40K 14 Sep 2026 · at $70.79 · 0.7% of stake Lalwani Nikhil PRESIDENT & CEO Sold on a plan $383.40K 15 Sep 2026 · at $71.00 · 1.6% of stake CAREY STEPHEN P. SVP & CFO Sold on a plan $208.05K 29 Sep 2026 · at $73.00 · 1.7% of stake
0 buys14 sales at will33 planned sales

Key numbers

Fiscal year 2025, ended 31 Dec 2025, as filed
Revenue
$883.37M
Net income
$78.34M
Free cash flow
$171.39M
Operating margin
12.6%
Net margin
8.9%
Return on equity
14.5%
Return on capital
10.7%
Debt to equity
0.57
Revenue growth, 1 yr
43.8%
Revenue growth, 5 yr
33.5% a year

Revenue and net income

Fiscal years, as filed with the SEC · point at a year for the detail
208M -23M FY20 Fiscal year 2020 Revenue $208.48M Net income $22.55M Margin -10.8% 216M -43M FY21 Fiscal year 2021 Revenue $216.14M Net income $42.60M Margin -19.7% · growth +3.7% 316M -48M FY22 Fiscal year 2022 Revenue $316.39M Net income $47.90M Margin -15.1% · growth +46.4% 487M 19M FY23 Fiscal year 2023 Revenue $486.82M Net income $18.78M Margin 3.9% · growth +53.9% 614M -19M FY24 Fiscal year 2024 Revenue $614.38M Net income $18.52M Margin -3.0% · growth +26.2% 883M 78M FY25 Fiscal year 2025 Revenue $883.37M Net income $78.34M Margin 8.9% · growth +43.8%
RevenueNet incomeLoss

Latest insider transactions

From Form 4, most recent first
All of them →
DateInsiderTypeValueOf own stake
29 Sep 2026 CAREY STEPHEN P.
SVP & CFO
Sold on a plan $208.05K 1.7%
15 Sep 2026 Lalwani Nikhil
PRESIDENT & CEO
Sold on a plan $383.40K 1.6%
14 Sep 2026 Cook Meredith
SR. VP, GENERAL COUNSEL & SEC.
Sold on a plan $35.40K 0.7%
11 Sep 2026 Thoma Jeanne
Director
Sold on a plan $71.53K 3.6%
31 Aug 2026 CAREY STEPHEN P.
SVP & CFO
Sold on a plan $207.48K 1.6%
25 Aug 2026 Lalwani Nikhil
PRESIDENT & CEO
Sold on a plan $401.22K 1.5%